L-glutamine Treatment in Patients With Diverticulosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing L-glutamine, a supplement that helps keep the gut healthy, on patients with diverticulosis. Diverticulosis causes small pouches in the colon that can be uncomfortable. The study aims to see if L-glutamine can reduce symptoms by supporting the gut lining and reducing inflammation. L-glutamine has been shown to reduce inflammation and support gut health in various gastrointestinal conditions.
Do I need to stop my current medications to join the trial?
The trial information does not specify if you need to stop taking your current medications. However, you cannot have taken any form of glutamine supplement within 30 days before the screening visit.
Is L-glutamine generally safe for human use?
How does the treatment L-glutamine differ from other treatments for this condition?
L-glutamine is unique because it is a conditionally essential amino acid that supports gut health and immune function, especially during stress or illness. Unlike other treatments, it can be taken orally, enterally, or parenterally, and it helps maintain intestinal integrity and prevent infections, which is particularly beneficial for patients undergoing trauma or surgery.678910
What data supports the effectiveness of the treatment L-glutamine?
Who Is on the Research Team?
Yutaka L Niihara, MD
Principal Investigator
Emmaus Medical, Inc.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive L-glutamine oral powder 15 grams twice daily
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- L-glutamine
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emmaus Medical, Inc.
Lead Sponsor